N
NeuroSense Therapeutics Ltd. (NRSN)
NCM – Real Time Price. Currency in USD
0.83
-0.00 (-0.24%)
At close: May 12, 2026, 4:00 PM EDT
0.83
+0.00 (0.24%)
After-hours: May 12, 2026, 7:38 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.83
-0.00 (-0.24%)
At close: May 12, 2026, 4:00 PM EDT
0.83
+0.00 (0.24%)
After-hours: May 12, 2026, 7:38 PM EDT
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from neurodegenerative diseases in the United States and internationally. The company’s lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for the treatment of Alzheimer’s, as well as under preclinical studies for the treatment of Parkinson’s disease. Its preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer’s disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.
| Name | Position |
|---|---|
| Dr. Niva Russek-Blum Ph.D. | Chief Technology Officer |
| Mr. Alon Ben-Noon | Co-Founder, CEO & Director |
| Mr. Or Eisenberg | Chief Financial Officer |
| Ms. Keren Pushett | Head of HR |
| Ms. Yael Barak | VP of Quality & Compliance |
| Date | Type | Document |
|---|---|---|
| 2026-04-28 | 6-K | ea0288103-6k_neurosense.htm |
| 2026-04-24 | 6-K | ea0287630-6k_neurosense.htm |
| 2026-04-06 | 6-K | ea0285169-6k_neuro.htm |
| 2026-03-31 | 20-F | ea0283072-20f_neurosense.htm |
| 2026-03-24 | 6-K | ea0283188-6k_neurosense.htm |
| 2026-03-16 | 6-K | ea0281799-6k_neuro.htm |
| 2026-03-11 | 6-K | ea0280853-6k_neurosense.htm |
| 2026-02-18 | 6-K | ea0277495-6k_neuro.htm |
| 2026-02-13 | 6-K | ea0276620-6k_neuro.htm |
| 2026-02-09 | 6-K | ea0276115-6k_neurosense.htm |